Bellevue Group’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Hold |
3,000
| – | – | ﹤0.01% | 132 |
|
|
2025
Q1 | $117K | Sell |
3,000
-1,400
| -32% | -$54.7K | ﹤0.01% | 139 |
|
|
2024
Q4 | $238K | Hold |
4,400
| – | – | ﹤0.01% | 140 |
|
|
2024
Q3 | $222K | Hold |
4,400
| – | – | ﹤0.01% | 145 |
|
|
2024
Q2 | $193K | Hold |
4,400
| – | – | ﹤0.01% | 149 |
|
|
2024
Q1 | $221K | Buy |
+4,400
| New | +$221K | ﹤0.01% | 152 |
|